Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Raux, G.
Right arrow Articles by Campion, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Raux, G.
Right arrow Articles by Campion, D.
Neurology 2000;55:1577-1579
© 2000 American Academy of Neurology
Brief Communications

Dementia with prominent frontotemporal features associated with L113P presenilin 1 mutation

G. Raux, PhD, R. Gantier, PhD, C. Thomas–Anterion, MD, J. Boulliat, MD, P. Verpillat, MD, D. Hannequin, MD, A. Brice, MD, PhD, T. Frebourg, MD, PhD and D. Campion, MD, PhD

From INSERM EPI 9906 (Drs. Raux, Gantier, Hannequin, Frebourg, and Campion), Rouen; CHU Bellevue (Dr. Thomas–Anterion), St. Etienne; CHR Bourg en Bresse (Dr. Boulliat); and INSERM U 289 (Drs. Verpillat and Brice), Paris, France.

Address correspondence and reprint requests to Dr. D. Campion, INSERM EPI 9906, IRFMP, Faculté de Médecine et de Pharmacie, 76183 Rouen, France; e-mail: dominique.campion{at}univ-rouen.fr

The authors report a presenilin 1 (PSEN1) mutation (L113P) in a family with six cases of dementia. The patients had personality changes and behavioral disorders, whereas spatial orientation and praxis were preserved late in the course of the illness. Neuroimaging features were consistent with the diagnosis of frontotemporal dementia. The authors conclude that PSEN1 mutations can be associated with clinical features of frontotemporal dementia.–1578




This article has been cited by other articles:


Home page
 NeurologyHome page
A. C. Bruni, L. Bernardi, R. Colao, E. Rubino, N. Smirne, F. Frangipane, B. Terni, S.A.M. Curcio, M. Mirabelli, A. Clodomiro, et al.
Worldwide distribution of PSEN1 Met146Leu mutation: A large variability for a founder mutation
Neurology, March 9, 2010; 74(10): 798 - 806.
[Abstract] [Full Text] [PDF]

Home page
 AM J ALZHEIMERS DIS OTHER DEMENHome page
A. Robles, M.J. Sobrido, M. Garcia-Murias, J.M. Prieto, M. Lema, D. Santos, and M. Paramo
Clinical Picture of a Patient With a Novel PSEN1 Mutation (L424V)
American Journal of Alzheimer's Disease and Other Dementias, February 1, 2009; 24(1): 40 - 45.
[Abstract] [PDF]

Home page
 Arch NeurolHome page
M. Doran, D. G. du Plessis, E. J. Ghadiali, D. M. A. Mann, S. Pickering-Brown, and A. J. Larner
Familial Early-Onset Dementia With Tau Intron 10 + 16 Mutation With Clinical Features Similar to Those of Alzheimer Disease
Arch Neurol, October 1, 2007; 64(10): 1535 - 1539.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. Shen and R. J. Kelleher III
The presenilin hypothesis of Alzheimer's disease: Evidence for a loss-of-function pathogenic mechanism
PNAS, January 9, 2007; 104(2): 403 - 409.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
B. F. Boeve, M. Baker, D. W. Dickson, J. E. Parisi, C. Giannini, K. A. Josephs, M. Hutton, S. M. Pickering-Brown, R. Rademakers, D. Tang-Wai, et al.
Frontotemporal dementia and parkinsonism associated with the IVS1+1G->A mutation in progranulin: a clinicopathologic study
Brain, November 1, 2006; 129(11): 3103 - 3114.
[Abstract] [Full Text] [PDF]

Home page
 AM J ALZHEIMERS DIS OTHER DEMENHome page
M. F. Mendez and A. McMurtray
Frontotemporal dementia-like phenotypes associated with presenilin-1 mutations.
American Journal of Alzheimer's Disease and Other Dementias, August 1, 2006; 21(4): 281 - 286.
[Abstract] [PDF]

Home page
 J Geriatr Psychiatry NeurolHome page
J. M. Ringman
What the Study of Persons At Risk for Familial Alzheimer's Disease Can Tell Us About the Earliest Stages of the Disorder: A Review
J Geriatr Psychiatry Neurol, December 1, 2005; 18(4): 228 - 233.
[Abstract] [PDF]

Home page
 J. Biol. Chem.Home page
D. E. Kang, I. S. Yoon, E. Repetto, T. Busse, N. Yermian, L. Ie, and E. H. Koo
Presenilins Mediate Phosphatidylinositol 3-Kinase/AKT and ERK Activation via Select Signaling Receptors: SELECTIVITY OF PS2 IN PLATELET-DERIVED GROWTH FACTOR SIGNALING
J. Biol. Chem., September 9, 2005; 280(36): 31537 - 31547.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
J. M. Ringman, C. Diaz-Olavarrieta, Y. Rodriguez, M. Chavez, L. Fairbanks, F. Paz, A. Varpetian, H. C. Maldonado, M. A. Macias-Islas, J. Murrell, et al.
Neuropsychological function in nondemented carriers of presenilin-1 mutations
Neurology, August 23, 2005; 65(4): 552 - 558.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
C. A. Saura, G. Chen, S. Malkani, S.-Y. Choi, R. H. Takahashi, D. Zhang, G. K. Gouras, A. Kirkwood, R. G. M. Morris, and J. Shen
Conditional Inactivation of Presenilin 1 Prevents Amyloid Accumulation and Temporarily Rescues Contextual and Spatial Working Memory Impairments in Amyloid Precursor Protein Transgenic Mice
J. Neurosci., July 20, 2005; 25(29): 6755 - 6764.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
N. S.M. Schoonenboom, C. Mulder, H. Vanderstichele, Y. A.L. Pijnenburg, G. J. Van Kamp, P. Scheltens, P. D. Mehta, and M. A. Blankenstein
Differences and Similarities between Two Frequently Used Assays for Amyloid {beta} 42 in Cerebrospinal Fluid
Clin. Chem., June 1, 2005; 51(6): 1057 - 1060.
[Full Text] [PDF]

Home page
 Arch NeurolHome page
A. J. Larner
Genotype-Phenotype Correlation in Early-onset Alzheimer Disease With Presenilin 1 Gene Mutations
Arch Neurol, May 1, 2004; 61(5): 801 - 801.
[Full Text] [PDF]